Atlas Trials

A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma

Clinical trial NCT07075328 · RECRUITING

Trial details

NCT number
NCT07075328
Sponsor
Otsuka Medical Devices Co., Ltd. Japan
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Adult T-Cell Leukemia/Lymphoma (ATLL)
Start date
2024-04-01
Primary completion
2028-02-28
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.